AVNS - Avanos Medical Inc Stock Price, Fair Value and News

23.14USD+0.22 (+0.96%)Market Closed

Market Summary

USD23.14+0.22

Market Closed

0.96%

AVNS Stock Price

View Fullscreen

AVNS RSI Chart

AVNS Valuation

Market Cap

1.1B

Price/Earnings (Trailing)

-17.08

Price/Sales (Trailing)

1.56

EV/EBITDA

18.4

Price/Free Cashflow

34.05

AVNS Price/Sales (Trailing)

AVNS Profitability

EBT Margin

0.40%

Return on Equity

-5.07%

Return on Assets

-3.74%

Free Cashflow Yield

2.94%

AVNS Fundamentals

AVNS Revenue

Revenue (TTM)

680.1M

Rev. Growth (Yr)

4.27%

Rev. Growth (Qtr)

-4.15%

AVNS Earnings

Earnings (TTM)

-62.2M

Earnings Growth (Yr)

-80%

Earnings Growth (Qtr)

-108.57%

Breaking Down AVNS Revenue

Last 7 days

5.2%

Last 30 days

20.7%

Last 90 days

27.9%

Trailing 12 Months

-4.9%

How does AVNS drawdown profile look like?

AVNS Financial Health

Current Ratio

2.28

Debt/Equity

0.14

Debt/Cashflow

0.19

AVNS Investor Care

Buy Backs (1Y)

1.63%

Diluted EPS (TTM)

-1.33

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	680.1M	0	0	0
2023	665.0M	663.5M	662.5M	673.3M
2022	603.7M	588.2M	576.4M	703.1M
2021	715.1M	737.8M	736.2M	587.0M
2020	713.8M	705.3M	719.6M	714.8M
2019	660.1M	671.4M	677.7M	697.6M
2018	622.3M	634.1M	648.7M	652.3M
2017	577.5M	588.9M	600.3M	611.6M
2016	523.3M	537.6M	551.9M	566.2M
2015	1.7B	1.6B	1.6B	509.0M
2014	1.7B	1.7B	1.7B	1.7B
2013	0	0	1.7B	1.7B
2012	0	0	0	1.7B

Get all data in R, Python etc through our Historical Stock Data APIs

About Avanos Medical Inc

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy and OrthogenRx's knee osteoarthritis pain relief injection products. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

CEO	Mr. Joseph F. Woody
WEBSITE	https://avanos.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	4044

Avanos Medical Inc Frequently Asked Questions

What is the ticker symbol for Avanos Medical Inc? What does AVNS stand for in stocks?

AVNS is the stock ticker symbol of Avanos Medical Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Avanos Medical Inc (AVNS)?

As of Fri Jul 26 2024, market cap of Avanos Medical Inc is 1.06 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AVNS stock?

You can check AVNS's fair value in chart for subscribers.

Is Avanos Medical Inc a good stock to buy?

The fair value guage provides a quick view whether AVNS is over valued or under valued. Whether Avanos Medical Inc is cheap or expensive depends on the assumptions which impact Avanos Medical Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AVNS.

What is Avanos Medical Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, AVNS's PE ratio (Price to Earnings) is -17.08 and Price to Sales (PS) ratio is 1.56. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AVNS PE ratio will change depending on the future growth rate expectations of investors.